Sponsored by:
The Missing catalyst in bioprocessing 4.0 is continuity
Leverage award-winning orchestration for your next-generation bioprocessing
The BioContinuum™ Platform is a comprehensive suite of solutions that has been helping biomanufacturers across the globe improve their bioprocessing through enhanced drug quality and process efficiency. Recognizing this impact, Merck has been voted the “Best Bioprocessing Innovation of the Year” award for the BioContinuum™ Platform at the Asia Pacific Bioprocessing Excellence Award 2022.
In an awards interview with Merrilee Whitney, Head of the BioContinuum™ Platform at Merck KgaA, Darmstadt, Germany, shares her insights on the future of bioprocessing and the BioContinuum™ Platform’s role in it. In this interview, she also discusses:
-
The trend and challenges in continuous processes within a biologics manufacturing
-
PAT, automation, and analytics components of the BioContinuum™ Platform
-
Use cases of the BioContinuum™ Platform and its value to end- users
-
Digitalization of biologics manufacturing processes and workflows
